Medical Xpress·4 min read·hard
Medicare prescriptions for Wegovy jumped after approval for heart disease
U
University of Southern California
✦AI Summary
Medicare prescriptions for the weight-loss drug Wegovy increased significantly after the FDA approved it for heart disease risk reduction. Despite this, researchers note that only a small fraction of eligible beneficiaries are currently receiving the treatment.
edited by Sadie Harley , reviewed by Andrew Zinin
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in